Marjorie A Rosenberg1. 1. School of Business and Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI 53706, USA. mrosenberg@bus.wisc.edu
Abstract
BACKGROUND: Simulation models analyzing the impact of treatment interventions and screening on the level of breast cancer mortality require an input of mortality from causes other than breast cancer, or competing risks. METHODS: This chapter presents an actuarial method of creating cohort life tables using published data that removes breast cancer as a cause of death. RESULTS: Mortality from causes other than breast cancer as a percentage of all-cause mortality is smallest for women in their forties and fifties, as small as 85% of the all-cause rate, although the level and percentage of the impact varies by birth cohort. CONCLUSION: This method produces life tables by birth cohort and by age that are easily included as a common input by the various CISNET modeling groups to predict mortality from other causes. Attention to removing breast cancer mortality from all-cause mortality is worthwhile, because breast cancer mortality can be as high as 15% at some ages.
BACKGROUND: Simulation models analyzing the impact of treatment interventions and screening on the level of breast cancer mortality require an input of mortality from causes other than breast cancer, or competing risks. METHODS: This chapter presents an actuarial method of creating cohort life tables using published data that removes breast cancer as a cause of death. RESULTS: Mortality from causes other than breast cancer as a percentage of all-cause mortality is smallest for women in their forties and fifties, as small as 85% of the all-cause rate, although the level and percentage of the impact varies by birth cohort. CONCLUSION: This method produces life tables by birth cohort and by age that are easily included as a common input by the various CISNET modeling groups to predict mortality from other causes. Attention to removing breast cancer mortality from all-cause mortality is worthwhile, because breast cancer mortality can be as high as 15% at some ages.
Authors: Jeanne S Mandelblatt; Kathleen A Cronin; Donald A Berry; Yaojen Chang; Harry J de Koning; Sandra J Lee; Sylvia K Plevritis; Clyde B Schechter; Natasha K Stout; Nicolien T van Ravesteyn; Marvin Zelen; Eric J Feuer Journal: Breast Date: 2011-10 Impact factor: 4.380
Authors: Amy Trentham-Dietz; Mehmet Ali Ergun; Oguzhan Alagoz; Natasha K Stout; Ronald E Gangnon; John M Hampton; Kim Dittus; Ted A James; Pamela M Vacek; Sally D Herschorn; Elizabeth S Burnside; Anna N A Tosteson; Donald L Weaver; Brian L Sprague Journal: Breast Cancer Res Treat Date: 2017-11-28 Impact factor: 4.872
Authors: Jeanne S Mandelblatt; Aimee M Near; Diana L Miglioretti; Diego Munoz; Brian L Sprague; Amy Trentham-Dietz; Ronald Gangnon; Allison W Kurian; Harald Weedon-Fekjaer; Kathleen A Cronin; Sylvia K Plevritis Journal: Med Decis Making Date: 2018-04 Impact factor: 2.583
Authors: Ronald E Gangnon; Natasha K Stout; Oguzhan Alagoz; John M Hampton; Brian L Sprague; Amy Trentham-Dietz Journal: Med Decis Making Date: 2018-04 Impact factor: 2.583
Authors: Montserrat Martinez-Alonso; Ester Vilaprinyo; Rafael Marcos-Gragera; Montserrat Rue Journal: Breast Cancer Res Date: 2010-08-03 Impact factor: 6.466
Authors: Marjorie A Rosenberg; Eric J Feuer; Binbing Yu; Jiafeng Sun; S Jane Henley; Thomas G Shanks; Christy M Anderson; Pamela M McMahon; Michael J Thun; David M Burns Journal: Risk Anal Date: 2012-07 Impact factor: 4.000
Authors: Jeanne S Mandelblatt; Kathleen A Cronin; Stephanie Bailey; Donald A Berry; Harry J de Koning; Gerrit Draisma; Hui Huang; Sandra J Lee; Mark Munsell; Sylvia K Plevritis; Peter Ravdin; Clyde B Schechter; Bronislava Sigal; Michael A Stoto; Natasha K Stout; Nicolien T van Ravesteyn; John Venier; Marvin Zelen; Eric J Feuer Journal: Ann Intern Med Date: 2009-11-17 Impact factor: 25.391